Onconic Therapeutics Inc. (KOSDAQ:476060)

Total Valuation

KOSDAQ:476060 has a market cap or net worth of KRW 940.05 billion. The enterprise value is 895.09 billion.

Market Cap	940.05B
Enterprise Value	895.09B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:476060 has 44.45 million shares outstanding. The number of shares has increased by 778.57% in one year.

Current Share Class	44.45M
Shares Outstanding	44.45M
Shares Change (YoY)	+778.57%
Shares Change (QoQ)	-1.88%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	5.02%
Float	4.33M

Valuation Ratios

The trailing PE ratio is 63.44.

PE Ratio	63.44
Forward PE	n/a
PS Ratio	31.95
PB Ratio	15.94
P/TBV Ratio	15.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	195.79
EV / Sales	30.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-211.13

Financial Position

The company has a current ratio of 12.10, with a Debt / Equity ratio of 0.00.

Current Ratio	12.10
Quick Ratio	11.84
Debt / Equity	0.00
Debt / EBITDA	0.10
Debt / FCF	-0.05
Interest Coverage	0.23

Financial Efficiency

Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 2.31%.

Return on Equity (ROE)	9.95%
Return on Assets (ROA)	2.15%
Return on Invested Capital (ROIC)	2.31%
Return on Capital Employed (ROCE)	2.89%
Revenue Per Employee	949.20M
Profits Per Employee	147.47M
Employee Count	31
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

Income Tax	-2.25B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	33,191.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.00
Average Volume (20 Days)	1,725,258

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:476060 had revenue of KRW 29.43 billion and earned 4.57 billion in profits. Earnings per share was 333.39.

Revenue	29.43B
Gross Profit	29.36B
Operating Income	1.71B
Pretax Income	2.32B
Net Income	4.57B
EBITDA	2.03B
EBIT	1.71B
Earnings Per Share (EPS)	333.39

Balance Sheet

The company has 45.19 billion in cash and 218.33 million in debt, giving a net cash position of 44.97 billion or 1,011.75 per share.

Cash & Cash Equivalents	45.19B
Total Debt	218.33M
Net Cash	44.97B
Net Cash Per Share	1,011.75
Equity (Book Value)	58.98B
Book Value Per Share	1,340.25
Working Capital	50.51B

Cash Flow

In the last 12 months, operating cash flow was -3.98 billion and capital expenditures -258.02 million, giving a free cash flow of -4.24 billion.

Operating Cash Flow	-3.98B
Capital Expenditures	-258.02M
Free Cash Flow	-4.24B
FCF Per Share	-95.38

Margins

Gross margin is 99.79%, with operating and profit margins of 5.80% and 15.54%.

Gross Margin	99.79%
Operating Margin	5.80%
Pretax Margin	7.88%
Profit Margin	15.54%
EBITDA Margin	6.91%
EBIT Margin	5.80%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:476060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-778.57%
Shareholder Yield	n/a
Earnings Yield	0.49%
FCF Yield	-0.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 10, 2025. It was a forward split with a ratio of 1.3333333333.

Last Split Date	Oct 10, 2025
Split Type	Forward
Split Ratio	1.3333333333

Scores

KOSDAQ:476060 has an Altman Z-Score of 29 and a Piotroski F-Score of 4.

Altman Z-Score	29
Piotroski F-Score	4